Skip to content

Eton Pharmaceuticals, Inc. ETON Change in Other Assets

Change in Other Assets at other companies

HRO
HarrowHROW
-$346K-15.7%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-$2.05M-618%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$7.02M+1.5%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
-$2.45M+65.1%
PVL
Palvella TherapeuticsPVLA
$357K+144%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$6.38M+282%

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s change in other assets?
Eton Pharmaceuticals, Inc. (ETON) reported change in other assets of -$1.75M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s change in other assets changed year-over-year?
Eton Pharmaceuticals, Inc.'s change in other assets increased by 41.0% year-over-year, from -$2.97M to -$1.75M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.